Cannabis and Pain Management

References

1. 1.↵
   CDC. Data and Statistics. CDC. Published 2019. Available at: https://www.cdc.gov/Marijuana/Data-Statistics.htm.
2. 2.↵
   National Center for Complementary and Integrative Health. Cannabis (marijuana) and cannabinoids: what you need to know. NCCIH. Published November 2019. Available at: https://www.nccih.nih.gov/health/cannabis-marijuana-and-cannabinoids-what-you-need-to-know.
3. 3.↵
   1. Thompson M

   . NPR choice page. Npr.org. Published 2019. Available at: https://www.npr.org/sections/codeswitch/2013/07/14/201981025/the-mysterious-history-of-marijuana.
4. 4.↵
   U.S. Department of Agriculture. Hemp. www.usda.gov. Available at: https://www.usda.gov/topics/hemp#:∼:text=The%20Agriculture%20Improvement%20Act%20of%202018%20(2018%20Farm%20Bill)%20authorized.
5. 5.↵
   1. Booth J,
   2. Bohlmann KJ

   . Terpenes in cannabis sativa – from plant genome to humans. Plant Sci 2019; 284:67–72.

   OpenUrlCrossRefPubMed
6. 6.↵
   NIDA Cannabis (Marijuana) DrugFacts. National Institute on Drug Abuse. Published December 24, 2019. Available at: https://nida.nih.gov/publications/drugfacts/cannabis-marijuana#mjextracts.
7. 7.↵
   1. Andreae MH,
   2. Carter GM,
   3. Shaparin N,
   4. et al

   . Inhaled cannabis for chronic neuropathic pain: a meta-analysis of individual patient data. J Pain 2015;16:1221–32.

   OpenUrlCrossRefPubMed
8. 8.↵
   1. Mücke M,
   2. Phillips T,
   3. Radbruch L,
   4. Petzke F,
   5. Häuser W

   . Cannabis-based medicines for chronic neuropathic pain in adults. Cochrane Database Syst Rev 2018;3:CD012182.

   OpenUrlCrossRefPubMed
9. 9.↵
   1. Fitzcharles M-A,
   2. Ste-Marie PA,
   3. Häuser W,
   4. et al

   . Efficacy, tolerability, and safety of cannabinoid treatments in the rheumatic diseases: a systematic review of randomized controlled trials. Arthritis Care Res (Hoboken) 2016;68:681–8.

   OpenUrlPubMed
10. 10.↵
    1. Johal H,
    2. Devji T,
    3. Chang Y,
    4. Simone J,
    5. Vannabouathong C,
    6. Bhandari M

    . Cannabinoids in chronic non-cancer pain: a systematic review and meta-analysis. Clin Med Insights Arthritis Musculoskelet Disord 2020; 13:1179544120906461.

    OpenUrlPubMed
11. 11.↵
    1. Yanes JA,
    2. McKinnell ZE,
    3. Reid MA,
    4. et al

    . Effects of cannabinoid administration for pain: a meta-analysis and meta-regression. Exp Clin Psychopharmacol 2019;27:370–82.

    OpenUrlPubMed
12. 12.
    1. Gazendam A,
    2. Nucci N,
    3. Gouveia K,
    4. Abdel Khalik H,
    5. Rubinger L,
    6. Johal H

    . Cannabinoids in the management of acute pain: a systematic review and meta-analysis. Cannabis Cannabinoid Res 2020;5:290–7.

    OpenUrlPubMed
13. 13.↵
    1. De Vita MJ,
    2. Moskal D,
    3. Maisto SA,
    4. Ansell EB

    . Association of cannabinoid administration with experimental pain in healthy adults: a systematic review and meta-analysis. JAMA Psychiatry 2018;75:1118–27.

    OpenUrlPubMed
14. 14.↵
    1. Mun CJ,
    2. Letzen JE,
    3. Peters EN,
    4. et al

    . Cannabinoid effects on responses to quantitative sensory testing among individuals with and without clinical pain: a systematic review. Pain 2020; 161:244–60.

    OpenUrlPubMed
15. 15.↵
    1. Hall W

    . What has research over the past two decades revealed about the adverse health effects of recreational cannabis use? Addiction 2015;110:19–35.

    OpenUrlCrossRefPubMedWeb of Science
16. 16.↵
    1. Bui QM,
    2. Simpson S,
    3. Nordstrom K

    . Psychiatric and medical management of marijuana intoxication in the emergency department. West J Emerg Med 2015; 16:414–7.

    OpenUrlPubMed
17. 17.↵
    1. Urits I,
    2. Gress K,
    3. Charipova K,
    4. et al

    . Cannabis use and its association with psychological disorders. Psychopharmacol Bull 2020 ;50:56–67.

    OpenUrlPubMed
18. 18.↵
    1. Crawford P,
    2. Go KV

    . Schizophrenia. Am Fam Physician 2022;106:388–96.

    OpenUrlPubMed
19. 19.↵
    1. Galli JA,
    2. Sawaya RA,
    3. Friedenberg FK

    . Cannabinoid hyperemesis syndrome. Curr Drug Abuse Rev 2011;4:241–9.

    OpenUrlCrossRefPubMed
20. 20.↵
    1. Galli JA,
    2. Sawaya RA,
    3. Friedenberg FK

    . Cannabinoid hyperemesis syndrome. Curr Drug Abuse Rev 2011;4:241–9.

    OpenUrlCrossRefPubMed
21. 21.↵
    1. Rella JG

    . Recreational cannabis use: pleasures and pitfalls. Cleve Clin J Med 2015;82:765–72.

    OpenUrlAbstract/FREE Full Text
22. 22.↵
    1. Shah S,
    2. Schwenk ES,
    3. Sondekoppam RV,
    4. et al

    . ASRA pain medicine consensus guidelines on the management of the perioperative patient on cannabis and cannabinoids. Reg Anesth Pain Med 2023;48:97–117.

    OpenUrlAbstract/FREE Full Text